Deepak M. Sahasrabudhe

2.2k total citations
67 papers, 1.5k citations indexed

About

Deepak M. Sahasrabudhe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Deepak M. Sahasrabudhe has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 17 papers in Surgery. Recurrent topics in Deepak M. Sahasrabudhe's work include Prostate Cancer Treatment and Research (11 papers), Bladder and Urothelial Cancer Treatments (9 papers) and Immunotherapy and Immune Responses (6 papers). Deepak M. Sahasrabudhe is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Bladder and Urothelial Cancer Treatments (9 papers) and Immunotherapy and Immune Responses (6 papers). Deepak M. Sahasrabudhe collaborates with scholars based in United States, Canada and Norway. Deepak M. Sahasrabudhe's co-authors include Craig S. McCune, Charlotte Ryan, Chunkit Fung, Robert O’Donnell, Alok A. Khorana, Edward M. Messing, Michael T. Milano, Christopher Cox, Shirley Eberly and Derick R. Peterson and has published in prestigious journals such as JAMA, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Deepak M. Sahasrabudhe

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepak M. Sahasrabudhe United States 21 580 532 376 281 271 67 1.5k
Andrea Papadia Italy 30 470 0.8× 453 0.9× 395 1.1× 231 0.8× 168 0.6× 131 2.5k
Pavel Strnad Czechia 22 435 0.8× 256 0.5× 256 0.7× 305 1.1× 152 0.6× 70 1.7k
Gloria A. Niehans United States 24 720 1.2× 696 1.3× 841 2.2× 638 2.3× 136 0.5× 45 2.1k
Christof Vulsteke Belgium 17 896 1.5× 770 1.4× 264 0.7× 277 1.0× 134 0.5× 77 1.6k
Scott Ernst Canada 25 741 1.3× 302 0.6× 553 1.5× 659 2.3× 159 0.6× 55 1.8k
Enzo Maria Ruggeri Italy 22 681 1.2× 354 0.7× 274 0.7× 535 1.9× 93 0.3× 103 1.4k
Milan J. Anadkat United States 22 733 1.3× 253 0.5× 276 0.7× 289 1.0× 399 1.5× 68 1.8k
Hugues Bittard France 21 253 0.4× 700 1.3× 666 1.8× 366 1.3× 164 0.6× 101 1.6k
Kenkichi Koiso Japan 22 421 0.7× 743 1.4× 451 1.2× 483 1.7× 103 0.4× 129 1.8k
Donna Lowe United Kingdom 21 506 0.9× 493 0.9× 381 1.0× 188 0.7× 204 0.8× 34 1.7k

Countries citing papers authored by Deepak M. Sahasrabudhe

Since Specialization
Citations

This map shows the geographic impact of Deepak M. Sahasrabudhe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak M. Sahasrabudhe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak M. Sahasrabudhe more than expected).

Fields of papers citing papers by Deepak M. Sahasrabudhe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak M. Sahasrabudhe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak M. Sahasrabudhe. The network helps show where Deepak M. Sahasrabudhe may publish in the future.

Co-authorship network of co-authors of Deepak M. Sahasrabudhe

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak M. Sahasrabudhe. A scholar is included among the top collaborators of Deepak M. Sahasrabudhe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak M. Sahasrabudhe. Deepak M. Sahasrabudhe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guercio, Brendan J., et al.. (2023). Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer. Cancers. 15(15). 3969–3969. 17 indexed citations
2.
Marshall, Jocelyn R., et al.. (2021). TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients. BMC Cancer. 21(1). 898–898. 17 indexed citations
3.
Prieto, Peter A., et al.. (2021). COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma. The Lancet Oncology. 22(6). e281–e281. 7 indexed citations
4.
Kilari, Deepak, Jason Zittel, Arpan Patel, et al.. (2020). 677P A phase II study of enzalutamide (Enz) with dutasteride (Dut) or finasteride (Fin) in men ≥ 65 years with hormone-naive systemic prostate cancer (HNSPCa): Final analysis. Annals of Oncology. 31. S540–S541. 1 indexed citations
5.
Kohli, Manish, Ann L. Oberg, Douglas W. Mahoney, et al.. (2019). Serum Proteomics on the Basis of Discovery of Predictive Biomarkers of Response to Androgen Deprivation Therapy in Advanced Prostate Cancer. Clinical Genitourinary Cancer. 17(4). 248–253.e7. 8 indexed citations
6.
Loh, Kah Poh, et al.. (2016). Targeted Therapy Based on Tumor Genomic Analyses in Metastatic Urachal Carcinoma. Clinical Genitourinary Cancer. 14(4). e449–e452. 13 indexed citations
7.
Pan, Chunliu, Shalini Singh, Deepak M. Sahasrabudhe, et al.. (2016). TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice. Endocrinology. 157(11). 4461–4472. 15 indexed citations
8.
Victor, Adrienne I. & Deepak M. Sahasrabudhe. (2016). Merkel Cell Carcinoma: Characteristics, Management, and What's on the Horizon. 1(2). 66–74.
9.
Fung, Chunkit, Chintan Pandya, Elizabeth A. Guancial, et al.. (2014). Impact of Bladder Cancer on Health Related Quality of Life in 1,476 Older Americans: A Cross-Sectional Study. The Journal of Urology. 192(3). 690–695. 40 indexed citations
10.
Feng, Changyong, et al.. (2012). An observational study of plasma vascular endothelial growth factors (VEGF) A and D expression in non-localized prostate cancer. Journal of Men s Health. 9(3). 182–189. 1 indexed citations
11.
Corbin, Kimberly S., et al.. (2010). Stereotactic Body Radiotherapy for Pulmonary Metastases from Soft Tissue Sarcomas: Excellent Local Lesion Control and Improved Patient Survival. International Journal of Radiation Oncology*Biology*Physics. 78(3). S614–S614.
12.
Evans, Elizabeth E., Alan S. Jonason, Mark Paris, et al.. (2006). C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Molecular Cancer Therapeutics. 5(11). 2919–2930. 43 indexed citations
13.
Ryan, Charlotte, et al.. (2004). The Influence of Host Response on Colorectal Cancer Prognosis. Clinical Colorectal Cancer. 4(1). 38–45. 37 indexed citations
14.
Pandya, Kishan J., Jennifer J. Griggs, Joseph D. Rosenblatt, et al.. (2004). Pilot Study using Gabapentin for Tamoxifen-induced Hot Flashes in Women with Breast Cancer. Breast Cancer Research and Treatment. 83(1). 87–89. 30 indexed citations
15.
Griggs, Jennifer J., Joseph D. Rosenblatt, Deepak M. Sahasrabudhe, et al.. (2001). Preliminary analysis of the pilot study using gabapentin on tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Research and Treatment. 69(3). 2 indexed citations
16.
Mieles, L, et al.. (2000). CD-20 expression in post-transplant lymphoproliferative disorders: Treatment with Rituximab. American Journal of Hematology. 65(2). 171–173. 29 indexed citations
17.
Sahasrabudhe, Deepak M., et al.. (1994). Effect of murine interferon ?/? on tumor-induced suppressor function. Cancer Immunology Immunotherapy. 39(6). 360–366. 8 indexed citations
18.
McCune, Craig S., et al.. (1990). Renal cell carcinoma treated by vaccines for active specific immunotherapy: Correlation of survival with skin testing by autologous tumor cells. Cancer Immunology Immunotherapy. 32(1). 62–66. 77 indexed citations
19.
Sahasrabudhe, Deepak M.. (1987). Inhibition of suppressor T lymphocytes by murine interferon beta.. The Journal of Experimental Medicine. 166(5). 1573–1578. 5 indexed citations
20.
Capizzi, Robert L., et al.. (1983). Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia.. Journal of Clinical Oncology. 1(12). 763–771. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Papadia Breakdown of academic impact, for papers by Pavel Strnad Breakdown of academic impact, for papers by Gloria A. Niehans Breakdown of academic impact, for papers by Christof Vulsteke Breakdown of academic impact, for papers by Scott Ernst Breakdown of academic impact, for papers by Enzo Maria Ruggeri Breakdown of academic impact, for papers by Milan J. Anadkat Breakdown of academic impact, for papers by Hugues Bittard Breakdown of academic impact, for papers by Kenkichi Koiso Breakdown of academic impact, for papers by Donna Lowe
Rankless by CCL
2026